The Summary
Researchers evaluated 12 DNA methylation (DNAm) algorithms to see which best predicted cancer risk and mortality. Analyzing data from 2,532 adults aged 50 and older in the NHANES dataset with a 17-year follow-up, they found that specific biological clocks, particularly GrimAge, strongly correlated with overall cancer risk. The association was especially significant in women, notably non-Hispanic White women, while no significant link was found in men. Additionally, the Horvath clock was linked to increased cancer mortality risk. These epigenetic clocks show promise as precision medicine tools for cancer risk stratification.
Why this is interesting
We often think of age strictly in chronological terms. However, your biological age, measured by how your DNA changes over time via epigenetics, tells a different story. This study reveals that people whose biological age is ticking faster than their chronological age face a higher risk of cancer and cancer-related death, particularly among women. For readers, this suggests that future routine tests could use these aging clocks to identify personal cancer risks early, allowing for highly targeted preventative care and personalized medicine long before actual symptoms appear.